JP2001502658A5 - - Google Patents

Download PDF

Info

Publication number
JP2001502658A5
JP2001502658A5 JP1997535761A JP53576197A JP2001502658A5 JP 2001502658 A5 JP2001502658 A5 JP 2001502658A5 JP 1997535761 A JP1997535761 A JP 1997535761A JP 53576197 A JP53576197 A JP 53576197A JP 2001502658 A5 JP2001502658 A5 JP 2001502658A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP1997535761A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001502658A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK1997/000146 external-priority patent/WO1997038011A1/en
Publication of JP2001502658A publication Critical patent/JP2001502658A/ja
Publication of JP2001502658A5 publication Critical patent/JP2001502658A5/ja
Withdrawn legal-status Critical Current

Links

JP09535761A 1996-04-03 1997-04-03 非樹状中心骨格ペプチド担体 Withdrawn JP2001502658A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK39896 1996-04-03
DK0398/96 1996-04-03
PCT/DK1997/000146 WO1997038011A1 (en) 1996-04-03 1997-04-03 Non-dendritic backbone peptide carrier

Publications (2)

Publication Number Publication Date
JP2001502658A JP2001502658A (ja) 2001-02-27
JP2001502658A5 true JP2001502658A5 (enExample) 2004-12-09

Family

ID=8093081

Family Applications (1)

Application Number Title Priority Date Filing Date
JP09535761A Withdrawn JP2001502658A (ja) 1996-04-03 1997-04-03 非樹状中心骨格ペプチド担体

Country Status (10)

Country Link
EP (1) EP0896582A1 (enExample)
JP (1) JP2001502658A (enExample)
KR (1) KR20000005429A (enExample)
CN (1) CN1215404A (enExample)
AU (1) AU704502B2 (enExample)
CA (1) CA2251464A1 (enExample)
HU (1) HUP9901254A3 (enExample)
NO (1) NO984644L (enExample)
NZ (1) NZ331596A (enExample)
WO (1) WO1997038011A1 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103239A (en) 1996-08-09 2000-08-15 Cel-Sci Corporation Modified HGP-30 heteroconjugates, compositions and methods of use
US6251866B1 (en) 1997-08-05 2001-06-26 Watson Laboratories, Inc. Conjugates targeted to the interleukin-2 receptor
JP2001523647A (ja) * 1997-11-18 2001-11-27 メディカル ユニバーシティー オブ サウス カロライナ 直鎖状抗原支持単位
US6472367B1 (en) * 1998-05-05 2002-10-29 Adherex Technologies, Inc. Compounds and methods for modulating OB-cadherin mediated cell adhesion
US7481999B2 (en) 1998-05-05 2009-01-27 Adherex Technologies, Inc. Compounds and methods for modulating OB-cadherin-mediated function
US7060284B1 (en) 1999-08-03 2006-06-13 The Ohio State University Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein
GB9930591D0 (en) * 1999-12-23 2000-02-16 Univ London Component for vaccine
WO2001060848A2 (en) * 2000-02-18 2001-08-23 Watson Pharmaceuticals, Inc. Conjugates targeted to target receptors
JP5048201B2 (ja) 2000-08-04 2012-10-17 ディーエムアイ バイオサイエンシズ インコーポレイテッド ジケトピペラジン類の使用方法とジケトピペラジン類を含む組成物
US7303907B2 (en) 2001-01-08 2007-12-04 Health Protection Agency Degradation and detection of TSE infectivity
WO2003085086A2 (en) * 2002-04-09 2003-10-16 The Scripps Research Institute Motif-grafted hybrid polypeptides and uses thereof
EP1534746A2 (en) * 2002-08-23 2005-06-01 Copenhagen Biotech Assets APS Composite peptide compounds for diagnosis and treatment of diseases caused by prion proteins
US7476509B2 (en) 2002-11-14 2009-01-13 Adherex Technologies Inc. Compounds and methods for modulating functions of nonclassical cadherins
US7354589B2 (en) * 2003-01-16 2008-04-08 The Wistar Institute Multiple antigenic agents and methods for using the same
CN102210852B (zh) 2003-05-15 2016-10-19 安皮奥制药股份有限公司 T-细胞介导的疾病的治疗
US7740860B2 (en) 2005-03-29 2010-06-22 The Wistar Institute Composition and method for preventing or treating a virus infection
EP1912680B1 (en) 2005-06-15 2014-11-26 The Ohio State University Research Foundation Her-2 peptides
KR100787393B1 (ko) 2006-03-23 2007-12-21 학교법인 한림대학교 세포 도입성 fk506 결합 단백질의 융합 단백질
JP5856843B2 (ja) 2008-05-27 2016-02-10 アンピオ ファーマシューティカルズ,インコーポレイテッド ジケトピペラジンを用いた医薬組成物
US20120128684A1 (en) 2008-08-25 2012-05-24 Burnham Institute For Medical Research Conserved Hemagglutinin Epitope, Antibodies to the Epitope and Methods of Use
US20100234283A1 (en) 2009-02-04 2010-09-16 The Ohio State University Research Foundation Immunogenic epitopes, peptidomimetics, and anti-peptide antibodies, and methods of their use
CN102297968B (zh) * 2010-06-28 2013-10-30 程小星 辅助诊断结核病的试剂盒
EP2613786A4 (en) 2010-09-07 2013-10-23 Dmi Acquisition Corp TREATMENT OF DISEASES
PH12014500685B1 (en) 2011-10-10 2018-10-03 Ampio Pharmaceuticals Inc Treatment of degenerative joint disease
JP2014530063A (ja) 2011-10-10 2014-11-17 アンピオ ファーマシューティカルズ,インコーポレイテッド 免疫寛容が高められた埋込み型医療用デバイス、ならびに製造方法および埋込み方法
HK1198812A1 (en) 2011-10-28 2015-06-12 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
CA2906864A1 (en) 2013-03-15 2014-09-18 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
US9827181B2 (en) 2013-06-05 2017-11-28 Industrial Technology Research Institute Method and pharmaceutical composition for hair growth
CN104231048B (zh) * 2013-06-05 2017-05-24 财团法人工业技术研究院 生发胜肽及药物组合物
EP4066836A1 (en) 2014-08-18 2022-10-05 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
EP3310375A4 (en) 2015-06-22 2019-02-20 Ampio Pharmaceuticals, Inc. USE OF LOW-MOLECULAR FRACTIONS OF HUMAN SERUMALBUMINE IN THE TREATMENT OF ILLNESSES
EP3392263A4 (en) * 2015-12-14 2020-03-04 Su Han POLYPEPTIDE COMPOUND, METHOD FOR PREPARING THE SAME, AND USE THEREOF
CN110636855B (zh) * 2017-03-28 2024-08-09 俄亥俄州创新基金会 人pd1肽疫苗及其用途
CN115087465A (zh) * 2019-10-29 2022-09-20 威斯康星校友研究基金会 肽-纳米颗粒缀合物
CN112851755B (zh) * 2021-01-13 2023-09-01 中国人民解放军军事科学院军事医学研究院 一种线性脂肽化合物及其制备方法与应用
CN119455134B (zh) * 2024-11-19 2025-12-05 四川大学 一种基于dna四面体的复合物及其制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2217319A (en) * 1988-04-19 1989-10-25 Synpharm Ltd Racemic and optically active fatty amino acids, their homo- abd hetero-oligomers and conjugates, the process of their production, their pharmaceutical composi
GB9215780D0 (en) * 1992-07-24 1992-09-09 Univ London Pharmacy Peptide compounds
US5674977A (en) * 1993-02-05 1997-10-07 The Ontario Cancer Institute Branched synthetic peptide conjugate
ATE209658T1 (de) * 1993-08-11 2001-12-15 Scripps Research Inst Anhand einer vorlage aufgebautes synthetisches protein
GB2282813A (en) * 1993-10-15 1995-04-19 Merck & Co Inc Annular antigen scaffolds comprising thioether linkages
WO1995031480A1 (en) * 1994-05-18 1995-11-23 S.P.I. Synthetic Peptides Incorporated Heterodimer polypeptide immunogen carrier composition and method

Similar Documents

Publication Publication Date Title
JP2000511776A5 (enExample)
JP2000511788A5 (enExample)
JP2000511435A5 (enExample)
JP2000514474A5 (enExample)
JP2000501599A5 (enExample)
JP2000504955A5 (enExample)
JP2001507081A5 (enExample)
JP2000505452A5 (enExample)
JP2000505690A5 (enExample)
JP2000513888A5 (enExample)
JP2000507075A5 (enExample)
JP2000503853A5 (enExample)
JP2000511806A5 (enExample)
JP2000517258A5 (enExample)
JP2000502472A5 (enExample)
JP2000501825A5 (enExample)
JP2000508645A5 (enExample)
JP2000507499A5 (enExample)
JP2000513072A5 (enExample)
JP2000504186A5 (enExample)
JP2000505983A5 (enExample)
JP2001500930A5 (enExample)
JP2000511842A5 (enExample)
JP2000508261A5 (enExample)
JP2001506757A5 (enExample)